Bjørnhart, B.; Hansen, K.H.; Asmussen, J.T.; Jørgensen, T.L.; Herrstedt, J.; Schytte, T.
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis. Cancers 2022, 14, 1682.
https://doi.org/10.3390/cancers14071682
AMA Style
Bjørnhart B, Hansen KH, Asmussen JT, Jørgensen TL, Herrstedt J, Schytte T.
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis. Cancers. 2022; 14(7):1682.
https://doi.org/10.3390/cancers14071682
Chicago/Turabian Style
Bjørnhart, Birgitte, Karin Holmskov Hansen, Jon Thor Asmussen, Trine Lembrecht Jørgensen, Jørn Herrstedt, and Tine Schytte.
2022. "Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis" Cancers 14, no. 7: 1682.
https://doi.org/10.3390/cancers14071682
APA Style
Bjørnhart, B., Hansen, K. H., Asmussen, J. T., Jørgensen, T. L., Herrstedt, J., & Schytte, T.
(2022). Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis. Cancers, 14(7), 1682.
https://doi.org/10.3390/cancers14071682